About this trial
This project will evaluate the impact of including Severe Combined Immunodeficiency into the newborn bloodspot screening panel. It will recruit parents and health professionals primarily from the sites where this new form of screening is being trialled well as additional sites where clinicians will be involved in the care of these babies and comparator groups are needed.
The proposed work will consist of two work packages. The first, a mixed-methods study conducted with families from the point of screening information being returned through to the child's fifth birthday. The second, a qualitative interview study conducted with health professionals during the clinical evaluation phase of the national pilot programme.
Eligibility criteria
Qualifiers
None
Disqualifiers
None
Trial design
Treatments tested in this trial
- SCID Screening
Treatment groups
6
Treatment groupsSee each treatment group below.
Sponsors and collaborators
King's College London
Lead sponsor
University of Manchester
Collaborator
University of Sheffield
Collaborator
Coventry University
Collaborator
National Health Service, United Kingdom
Collaborator